Browse Obstetrics/Gynecology Articles by Topic

Join the Mission: Increase HPV Vaccinations for Girls and Boys

The 67 National Cancer Institute-designated cancer centers and a host of other cancer organizations now are fully endorsing the goal of eliminating cancers caused by human papillomavirus (HPV) through gender-neutral HPV vaccination and evidence-based cancer screening.

Management of IUGR: Revisited

This special feature will discuss enlightening information that has surfaced about management of intrauterine growth restriction.

Ovarian Function: Use It or Lose It

A larger epidemiologic study from Norway found no association between early menarche and age of menopause. Women with early menarche experience a longer fertility window, which may increase certain risks.

An Arcuate Uterus (Apparently) Does Not Impair Fertility

No decreases in implantation rates and live birth rates were present in a retrospective study from a single fertility center examining outcomes of in vitro fertilization in women with an arcuate uterus.

Does Childhood Adversity Affect the Menopausal Transition?

The number and timing of adverse childhood experiences in relation to puberty affect the risk of incident major depressive disorder in the menopausal transition.

With Funding Announcement, Trump Begins Reshaping Title X

Funding announcement to reshape Title X.

What’s Your Approach to Abnormal Uterine Bleeding?

Statistics indicate that one-third of outpatient gynecologist visits are for abnormal uterine bleeding, with the condition accounting for more than 70% of gynecologic consultations in the perimenopausal and postmenopausal years.

Research Examines Self-administered DMPA

New research indicates that use of subcutaneous depot medroxyprogesterone (DMPA-SC, marketed as Sayana Press, Pfizer Inc.) may help women to continue using injectable contraception longer than women who receive traditional intramuscular injections.

Push Is on to Combat Drug-resistant Gonorrhea

In a recently released study, Centers for Disease Control and Prevention (CDC) researchers report that while 81% of patients diagnosed with gonorrhea were treated using dual therapy, nearly one in five were treated with a different regimen.

FDA Issues Restrictions for Sterilization Option

The Food and Drug Administration has issued new restrictions regarding the sale and distribution of the permanent contraceptive device, Essure.